Crossmark

The HBV capsid modulators derived from sulfamoylbenzamides and benzamides: an overview of the progress of patents

Published Online: 2023-07-04

Published Print: 2023-07

Authors

Hwang, Nicky

Clement, Jason A.

Guo, Ju-Tao

Du, Yanming https://orcid.org/0000-0002-4665-8348
Funding

Funding for this research was provided by:

National Institutes of Health (AI113267, AI113267)

Commonwealth of Pennsylvania
License Information

Text and Data Mining valid from 2023-07-01

Version of Record valid from 2023-07-01
More Information

Article History

Received: 2 May 2023

Accepted: 23 May 2023

First Online: 4 July 2023

Compliance with ethical standards

:

: The authors declare no competing interests.

Document is current